BSE filing, NSE: SYSCHEM. Summary written from the filing by ALFA Finder's alert engine.
Syschem (India) Ltd: key numbers
- Share price
- ₹36.62
- Market cap
- ₹179.5 Cr
- Revenue (annual)
- ₹573.8 Cr
- Net profit (annual)
- ₹10.93 Cr
- P/E (TTM)
- 29.1×Sector 46.1×
- Promoter holding
- 63.38%+3.23% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syschem (India) Ltd
All →Syschem (India) Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹12,979 lakh (+10% YoY), EBITDA ₹466 lakh, PAT ~₹190 lakh after Q1 loss. Turnaround narrative; no explicit guidance.
Syschem (India) Q2 FY27 Results: Net Profit ₹1.9 Cr, Up 0.0% YoY
Syschem (India) Ltd reported revenue from operations of ₹129.8 Cr (+10.1% YoY) and net profit of ₹1.9 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1.9 Cr · +0.0% YoY
Syschem (India) Legal & Regulatory
Syschem (India) Limited has paid a full settlement of ₹1.25 Crore to Lotus Builders. The company is now moving to withdraw pending NCLT litigation.
- Value
- ₹1.25 Cr
Syschem (India) Other Announcement
Syschem (India) Limited reported no deviations in the utilization of funds raised through its preferential issue. As of September 30, 2026, the company utilized Rs. 15.99 Crore.
- Value
- ₹16.00 Cr
Syschem (India) Other Announcement
Syschem India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This routine disclosure details the current shareholding structure.
Syschem (India) Management Change
Syschem India Ltd announced a leadership reshuffle: Mr. Suninder Veer Singh was designated as Managing Director, while Mr. Ranjan Jain transitioned to Whole-Time Director.
Other board meeting date announcements
All →Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.